Pilot Study of Crenolanib Combined With Standard Salvage Chemotherapy in Subjects With R/R AML
Clinical trial NCT02626338 · COMPLETED
Trial details
- NCT number
- NCT02626338
- Sponsor
- Arog Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2018-02-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.